← Back to Search

Non-App User Study Participant for Colorectal Surgery

N/A
Waitlist Available
Led By Malcolm H Squires, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days following hospital discharge
Awards & highlights

Summary

The purpose of this study is to evaluate whether patient-centered educational material delivered before and immediately after surgery can help improve outcomes for patients undergoing colorectal surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days following hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days following hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
30-day readmission
Perioperative ERAS metric completion rate
Postoperative complications
+1 more
Secondary study objectives
Postoperative Opioid Consumption

Trial Design

2Treatment groups
Experimental Treatment
Group I: SeamlessMD Mobile ApplicationExperimental Treatment1 Intervention
Participants enrolling in SeamlessMD will be prompted by the mobile app to electronically complete a validated quality-of-life assessment, the Quality of Recovery (QoR-15) evaluation over 30 days. Participants will also be prompted by the app to record their daily narcotic consumption via an "Opioid Tracker" page that requests participants enter the number of doses taken for each narcotic medication in the last 24 hours.
Group II: Non-App User Study ParticipantExperimental Treatment0 Interventions
Participants will receive on postoperative day one (POD1) in the hospital a one-page paper survey of the same questions prompted by the SeamlessMD app regarding completion of preoperative ERAS metrics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SeamlessMD® Mobile Application
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,632 Total Patients Enrolled
Atrium Health Levine Cancer InstituteOTHER
24 Previous Clinical Trials
1,764 Total Patients Enrolled
Malcolm H Squires, MDPrincipal InvestigatorWake Forest University Health Sciences
~16 spots leftby Sep 2025